Skip to main content
FinSpry Logo
FinSpry
SABS logo
SABS
(NASDAQ)
SAB Biotherapeutics, Inc.
$3.88-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

SAB Biotherapeutics (SABS) Stock Price & Financial Analysis

SAB Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.83 - $3.97
52-Week High$6.60
52-Week Low$1.00
Open$3.89
Volume205.32K
Average Volume (3M)205.32K
Market Cap238.00M
Shares Outstanding61.34M
P/E Ratio (TTM)17.88
Price to Book (P/B)1.57
EV/EBITDA14.11
50-Day MA$4.02
200-Day MA$3.10
52-Week Change214.63%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About SAB Biotherapeutics

What is the current stock price for SABS?

As of the latest trading session, SABS stock trades at $3.88. The 52-week range is $1.00–$6.60, with a day range of $3.83–$3.97.

What is the P/E ratio for SABS?

SAB Biotherapeutics's trailing P/E ratio is 17.9, meaning investors pay $17.9 for every $1 of annual earnings. SAB Biotherapeutics operates in the Healthcare sector.

Does SABS pay dividends?

SAB Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SABS?

Based on 3 analysts, the consensus for SABS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SABS?

SAB Biotherapeutics's market capitalization is $238.0M, classifying it as a micro-cap company. SAB Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.